Shilpa Medicare stock surges post USFDA approval Shilpa Medicare stock surges post USFDA approval Avalokita Pandey / Monday, February 3, 2020 / Article rating: 5.0 The share price of Shilpa Medicare gained around six per cent today, after the company received an approval from US Food and Drug Administration (USFDA) for Pirfenidone tablets, which is used to treat idiopathic pulmonary fibrosis.
Ahluwalia Contracts win order worth Rs 1,254 crore Ahluwalia Contracts win order worth Rs 1,254 crore Amir Shaikh / Monday, February 3, 2020 / Article rating: 5.0 Ahluwalia Contracts informed the bourses that it has secured an order worth Rs 1,254 crore from Central Public Works Department (CPWD), Jammu (J&K)
Ten stocks close to their 52-week high Ten stocks close to their 52-week high DSIJ Intelligence / Monday, February 3, 2020 / Article rating: 4.4 The market opened in the red on February 3, 2020. The previous trading session witnessed the Sensex going down by 987.96 points to end at 39,735.53 and the Nifty was down by 300.25 points to close at 11661.85.
Despite 29 per cent jump in PAT, ITC slumps as government increases NCCD Despite 29 per cent jump in PAT, ITC slumps as government increases NCCD Amir Shaikh / Monday, February 3, 2020 / Article rating: 2.5 PAT for the quarter jumped nearly 29 per cent YoY Rs 4,142 crore. This was due to a lower effective tax rate in Q3FY20.
Ten stocks close to their 52-week low Ten stocks close to their 52-week low DSIJ Intelligence / Monday, February 3, 2020 / Article rating: 5.0 The market opened in the red on February 3, 2020. The previous trading session witnessed the Sensex going down by 987.96 points to end at 39,735.53 and the Nifty was down by 300.25 points to close at 11661.85.
Five stocks with buying interest Five stocks with buying interest DSIJ Intelligence / Monday, February 3, 2020 / Article rating: 5.0 The market opened in the red on February 3, 2020. The previous trading session witnessed the Sensex going down by 987.96 points to end at 39,735.53 and the Nifty was down by 300.25 points to close at 11661.85.
Zydus Cadila receives nod for type 2 Diabetes treatment drug Zydus Cadila receives nod for type 2 Diabetes treatment drug DSIJ Intelligence / Monday, February 3, 2020 / Article rating: 5.0 Zydus Cadila has received an approval from Drug Controller General of India (DGIA) for the use of Saroglitazar Magnesium in the treatment of type 2 Diabetes Mellitus as an additional therapy with Metformin.
Abolition of DDT: Dividend Yield MFs to benefit? Abolition of DDT: Dividend Yield MFs to benefit? DSIJ Intelligence / Monday, February 3, 2020 / Article rating: 5.0 With the recent Budget announcements, Finance Minister Nirmala Sitharaman abolished the Dividend Distribution Tax (DDT). So, let’s find out whether abolishing DDT would benefit dividend yield funds or not!
Ten per cent TDS on your mutual fund income Ten per cent TDS on your mutual fund income DSIJ Intelligence / Monday, February 3, 2020 / Article rating: 4.0 For many mutual fund investors, the announcement of 10 per cent tax on their mutual fund income above Rs 5,000 has come as a rude shock.
NCC receive new orders worth Rs 530 crore NCC receive new orders worth Rs 530 crore DSIJ Intelligence / Monday, February 3, 2020 / Article rating: 3.0 Nagarjuna Construction Company (NCC) Limited announced that the company has received three new orders totaling to Rs 530 crore, which is exclusive of GST in the month of January 2020.